Detail akcie Enzolytics Rg online

Business Summary: Enzolytics, Inc. is a drug development company. The Company is focused on commercializing its licensed proprietary proteins and monoclonal antibodies to treat debilitating infectious diseases to include the additional contracted areas of sales, marketing and distribution of medical devices, medical testing and nutraceutical products. Its subsidiaries include BioClonetics lmmunotherapy, Inc. and Biogenysis, Inc.
Financial Summary: BRIEF: For the nine months ended 30 September 2013, Enzolytics Inc revenues was not reported. Net loss decreased 91% to $81K. Lower net loss reflects Professional fees paid by issuance decrease of 97% to $16K (expense), Other Non Rec. I/E - Non Business Activ. decrease from $284K (expense) to $0K, General and administrative decrease of 16% to $48K (expense).